Deciphering the molecular basis of the kappa opioid receptor selectivity: A Molecular Dynamics study - ScienceDirect
Buprenorphine Education: Technical explanation of Buprenorphine mu receptor, affinity of agonist and antagonist
κ-opioid receptor - Wikipedia
Kappa Opioid Receptors Drive a Tonic Aversive Component of Chronic Pain | Journal of Neuroscience
Kappa opioid receptor signaling in the brain: Circuitry and implications for treatment | Semantic Scholar
Frontiers | A Review of the Therapeutic Potential of Recently Developed G Protein-Biased Kappa Agonists
Role of kappa-opioid receptors in stress and anxiety-related behavior. - Abstract - Europe PMC
Kappa Opiate Receptor Agonist - an overview | ScienceDirect Topics
Opioid agonists, mixed agonist-antagonists and partial agonists | Osmosis
Opioid receptors: drivers to addiction? | Nature Reviews Neuroscience
Medications Used in Opioid Maintenance Treatment
The Role of Dynorphin and the Kappa Opioid Receptor in the Symptomatology of Schizophrenia: A Review of the Evidence
Kappa Opioid Receptors Drive a Tonic Aversive Component of Chronic Pain | Journal of Neuroscience
The Therapeutic Potential of κ-Opioids for Treatment of Pain and Addiction | Neuropsychopharmacology
A systematic review on the kappa opioid receptor and its ligands: New directions for the treatment of pain, anxiety, depression, and drug abuse - ScienceDirect
The main causes of narcotic addiction (e.g., morphine) and strategies... | Download Scientific Diagram
Dynorphin/Kappa Opioid Receptor Signaling in Preclinical Models of Alcohol, Drug, and Food Addiction - ScienceDirect
Structure-Based Discovery of New Antagonist and Biased Agonist Chemotypes for the Kappa Opioid Receptor | Journal of Medicinal Chemistry
Selective kappa opioid antagonists for treatment of addiction, are we there yet? | Semantic Scholar
Signaling Properties of Structurally Diverse Kappa Opioid Receptor Ligands: Toward in Vitro Models of in Vivo Responses | ACS Chemical Neuroscience
Opioids to Treat Depression: The Jury Is Out
Frontiers | Crosstalk Between Kappa Opioid and Dopamine Systems in Compulsive Behaviors
Discovery of Small Molecule Kappa Opioid Receptor Agonist and Antagonist Chemotypes through a HTS and Hit Refinement Strategy | ACS Chemical Neuroscience
Selective kappa opioid antagonists for treatment of addiction, are we there yet? | Semantic Scholar
A Narrative Pharmacological Review of Buprenorphine: A Unique Opioid for the Treatment of Chronic Pain | SpringerLink
Targeting the Kappa Opioid Receptor to Reduce Drug Use and Relapse | National Institute on Drug Abuse (NIDA)
